Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Depression

fMRI neurofeedback shows promise for depression treatment

by Vladimir Hedrih
January 6, 2025
in Depression
(Photo credit: DALL·E)

(Photo credit: DALL·E)

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

A systematic review of fMRI neurofeedback interventions in depression shows that this type of training can modulate neural activity related to depression in a single session. A learning effect is also evident over multiple sessions. The paper was published in Clinical Neurophysiology.

fMRI neurofeedback is a technique that uses real-time functional magnetic resonance imaging (fMRI) to train individuals to consciously regulate their brain activity. Participants observe visual representations of their brain activity, typically displayed as a graph or thermometer, while engaging in specific mental strategies to modulate that activity. This method targets specific brain regions or networks associated with functions such as emotion regulation, pain perception, or cognitive control.

Neurofeedback aims to improve self-regulation of brain activity, potentially offering therapeutic benefits for conditions like anxiety, depression, PTSD, and chronic pain. The process involves repeated training sessions, during which individuals practice and refine their ability to influence brain activity patterns. fMRI neurofeedback is non-invasive, but it requires specialized equipment and expertise, making it less accessible than other neurofeedback methods, such as EEG.

Study author Ana Rita Barreiros and her colleagues sought to integrate the scientific findings on the effects of fMRI neurofeedback interventions in depression. They searched five databases of scientific research publications (PubMed, ScienceDirect, Web of Science, Scopus, and PsycINFO) using keywords such as “fMRI,” “functional magnetic resonance imaging,” “functional MRI,” combined with “depression,” “major depression,” or “major depressive disorder,” and “neurofeedback.”

The researchers looked for peer-reviewed publications written in English that explored the effects of fMRI neurofeedback interventions and included at least one group of participants with major depressive disorder. Ultimately, their search yielded 16 studies that met these criteria. Ten of these studies focused on individuals with major depressive disorder (310 participants), three on recurrent major depressive disorder (67 participants), and three included individuals with mild depression (23 participants). The number of participants per study ranged from 6 to 43, and 77% of the participants were female.

The authors focused on the effects of fMRI neurofeedback training on functional connectivity and BOLD activation patterns reported by these studies. The BOLD signal measures changes in blood oxygenation and flow in specific brain areas. It serves as an indirect indicator of neural activity, as active regions consume more oxygen, prompting an increase in oxygen-rich blood flow to that area. This alters the ratio of oxygenated to deoxygenated hemoglobin in that region. fMRI can detect these changes, allowing researchers to infer neural activity.

Overall, most studies indicated that fMRI neurofeedback training can modulate BOLD activity even within a single session. However, a significant learning effect was observed over multiple sessions. Neurofeedback training targeting specific brain regions led to changes in functional connectivity across broad neural networks, including the default-mode network (active when at rest) and the executive control network (primarily involving the prefrontal cortex and parietal regions, responsible for high-level cognitive functions like decision-making, problem-solving, and regulating attention and behavior).

“fMRI neurofeedback shows promise as a modulatory technique for depression, with the potential to induce significant changes in neural activity and connectivity of networks implicated in depression.”, study authors concluded.

The study integrates the findings of existing studies on the effects of fMRI neurofeedback training in individuals with depression. However, the studies included in this analysis were methodologically diverse and did not follow standardized protocols, limiting how generalizable the results are.

The paper, “fMRI neurofeedback for the modulation of the neural networks associated with depression,” was authored by Ana Rita Barreiros, Isabella B. Breukelaar, Anthony W.F. Harris, and Mayuresh S. Korgaonkar.

RELATED

Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
Depression

Antidepressant withdrawal symptoms may be more common and more severe than some studies suggest

August 22, 2025

A new study challenges previous claims that antidepressant withdrawal is rare or mild. Researchers found that more than half of patients report symptoms when discontinuing, suggesting earlier reviews relying on short-term trials may have underestimated the risks.

Read moreDetails
The neurobiology of trauma: How childhood adversity alters brain development
Depression

Esketamine nasal spray shows rapid antidepressant effects as standalone treatment

August 16, 2025

A new clinical trial suggests that esketamine nasal spray, used alone without oral antidepressants, may reduce depressive symptoms in patients with treatment-resistant depression. The fast-acting treatment showed benefits within 24 hours and sustained effects over four weeks.

Read moreDetails
Specific narcissistic traits appear to heighten veteran PTSD risk
Depression

Depressed individuals have heightened C-reactive protein-to-albumin ratio

August 13, 2025

New research links an elevated C-reactive protein-to-albumin ratio—a blood marker reflecting inflammation and nutrition status—to higher odds of depression. The findings raise the possibility that this widely available biomarker could play a role in mental health screening.

Read moreDetails
Dark Triad personality traits linked to more favorable attitudes toward cognitive enhancement
Alzheimer's Disease

Antidepressant vortioxetine linked to greater cognitive and mood improvements in Alzheimer’s patients

August 9, 2025

A year-long study suggests vortioxetine may offer greater improvements in both cognition and mood for people with Alzheimer’s disease and depression compared to other antidepressants, potentially making it a promising treatment option alongside standard Alzheimer’s therapies.

Read moreDetails
New neuroscience research reveals the remarkable impact of exercise on brain cells
Depression

Neuroscientists make fascinating breakthrough linking disinhibited brain networks to depression

August 6, 2025

Neuroscientists used rare intracranial recordings to trace how moment-to-moment brain activity in the prefrontal cortex reflects daily mood changes. They found that depression worsens as cortical communication becomes disinhibited and hemispheric activity grows increasingly imbalanced.

Read moreDetails
Neuroscientists pinpoint part of the brain that deciphers memory from new experience
Depression

Amygdala enlargement linked to future onset of depression

August 5, 2025

A new study found that structural brain differences—specifically in the amygdala—may predict who will develop depression. These changes were present before symptoms began, suggesting a possible early biomarker for identifying individuals at elevated risk for first-time depressive episodes.

Read moreDetails
Depressed individuals who feel stigmatized are more likely to contemplate suicide
Depression

Depressed individuals who feel stigmatized are more likely to contemplate suicide

July 29, 2025

A new study has found that people with depression who internalize stigma are more likely to experience suicidal thoughts. The findings highlight how shame and self-judgment can intensify suicidal ideation, independent of depression severity.

Read moreDetails
School shooters often grew up with guns as key symbols of bonding and belonging
Depression

Exposure to gun violence linked to depression and suicide risk

July 27, 2025

Individuals who frequently experience or witness gun violence are more likely to report symptoms of depression and suicidal ideation, according to nationwide survey data, highlighting the mental health risks associated with exposure to firearm-related incidents.

Read moreDetails

STAY CONNECTED

LATEST

Can facial fillers and Botox-like injections improve your dating prospects or how others see you?

A simple cognitive vaccine can make you more resistant to misinformation

Psychopathic men and less selective women report more sex via Tinder

Letting loose with a swear word may actually make you stronger

Pilates may help treat female sexual dysfunction, new study indicates

Is ChatGPT making us stupid?

Children raised in poverty are less likely to believe in a just world

Religious attendance linked to greater support for youth tackle football, study finds

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy